Dr. Smoot is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9427 SW Barnes Rd
Ste 595
Portland, OR 97225Phone+1 503-216-1060Fax+1 503-216-1066
Education & Training
Oregon Health & Science University (OHSU Health)Residency, Neurology, 2000 - 2004
University of Cincinnati College of MedicineClass of 2000
Certifications & Licensure
OR State Medical License 2003 - 2025
WA State Medical License 2004 - 2008- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Measurement of Relaxin Peptide in Multiple Sclerosis (MS) Start of enrollment: 2013 Sep 20
- Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
- Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab Start of enrollment: 2017 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsThree-year clinical outcomes of relapsing multiple sclerosis patients treated with dimethyl fumarate in a United States community health center.Kyle Smoot, Kateri J. Spinelli, Tamela Stuchiner, Lindsay Lucas, Chiayi Chen
Multiple Sclerosis. 2018-06-01 - 5 citationsReducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of terifluno...Stanley Cohan, Keith R. Edwards, Lindsay Lucas, Tiffany Gervasi-Follmar, Judy O'Connor
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2019-01-16 - 42 citationsClinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective...Stanley Cohan, Harold L. Moses, Jonathan Calkwood, Carlo Tornatore, Chris LaGanke
Multiple Sclerosis and Related Disorders. 2018-02-26
Press Mentions
Report: Flag Football May Not Be Safer for KidsFebruary 20th, 2017
Think Flag Football Is Safer Than Tackle Football? Study Says Guess Again — 8 Key Takeaways FeaturedFebruary 17th, 2017
Expert Available to Discuss Higher Risk of Injury in Youth Flag Football Compared to Youth Tackle FootballFebruary 16th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
